DKK3 and breast carcinoma: Collectively, our results demonstrate that DKK3 functions as a tumour suppressor inhibiting Wnt/β-catenin signalling in breast carcinogenesis, and raises the possibility of DKK3 methylation as a potential tumour marker and future therapeutic target for breast cancer.